Project Grant R01AI189284
Award Date 8/1/25
Completion Date 7/31/30
Dollars Obligated $812K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92103, USA
Similar Awards
- The University of California, San Diego (UCSD) was awarded a $2,911,005 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a retrospective study evaluating the impact of public health activities related to the HIV care continuum in New York City. The project, titled "CHROME: Continuum of HIV Response through Observational Molecular Epidemiology", aims to determine if individuals without...
- The University of California, San Diego (UCSD) received a $702,788 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), to establish the San Diego Implementation Science Hub (SD IS Hub). The SD IS Hub applies implementation science principles to support the objectives of the NIH Ending the HIV Epidemic (EHE) initiative by providing technical consultation and support to...
- This $658,019 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The purpose of the award is to establish a Rigorous, Rapid, and Relevant Evidence Adaptation and Implementation (R3EDI) Consultation Hub to support the Ending the HIV Epidemic (EHE) initiative. The R3EDI Hub will provide technical assistance, training resources, and consultation support to EHE...
- The University of Chicago received a $126,435 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to pilot the implementation of electronic patient-reported sexual health data into electronic medical records (EMRs) to identify individuals who would benefit from pre-exposure prophylaxis (PrEP) for HIV prevention. The project, titled "INFOHIV: Clinical Informatics for Optimizing HIV Prevention and...
- This Project Grant award of $285,816 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to enhance understanding of ADP-ribosylation (ADPR) and its role in HIV-1 latency and reactivation. The awardee, The Regents of the University of California, San Francisco, will conduct biochemical, proteomic, and cellular assays to identify global proteomic changes to ADPR during HIV-1 latency and reactivation,...
- The U.S. Department of Health and Human Services' HIV Prevention Activities Non-Governmental Organization Based program (CFDA 93.939) awarded a $1,702,777.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on July 1, 2025. The grant supports UCSF's comprehensive efforts to prevent, diagnose, and address HIV transmission through targeted community-based interventions, with a focus on developing and implementing effective HIV prevention strategies for high-risk...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $1,505,785 Project Grant to Northwestern University to support the HIV Implementation Science Coordination Initiative (ISCI). The grant, awarded on Sep 3, 2025, with a completion date of Aug 31, 2030, aims to: 1) Integrate implementation and effectiveness data across NIAID's Ending the HIV Epidemic (EHE)-funded projects to create...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,972 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Sponsored Projects Services, to study the role of the cellular protein EHD4 in restricting HIV-1 infection. The research aims to determine the mechanism by which EHD4 decreases the infectivity of HIV-1 particles by impacting the incorporation of...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- The University of California, San Diego (UCSD) was awarded a $3,194,992.00 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on July 16, 2025, supports research to study the roles and regulation of tissue-resident CD8 T cells during a persistent viral infection. The research aims to investigate the mechanisms that allow immune cells to adapt and maintain a long-term...